Former CEO Anne Wojcicki has successfully pushed for a higher purchase price for 23andMe, now reaching $305 million, after the company initially planned to sell to Regeneron for $256 million. This bid comes after Wojcicki's earlier offer of $40 million prior to the company's bankruptcy filing in March.
Anne Wojcicki's nonprofit has successfully won the bidding for 23andMe, offering $305 million for the DNA-testing company's assets. This comes after Regeneron, a biotech firm, initially led the bidding with a $256 million offer during a bankruptcy auction.